← All Pliant Therapeutics, INC filings

Pliant Therapeutics, INC Form 4 insider transactions

NASDAQ
PLRX
Pliant Therapeutics, INC
Form 4: Pliant Therapeutics Director Acquires 26,764 Shares Via Option Grant
Director John T. Curnutte acquired 26,764 shares of Pliant Therapeutics through an option grant on June 13, 2024.
NASDAQ
PLRX
Pliant Therapeutics, INC
Form 4: Pliant Therapeutics Director Acquires 53,528 Stock Options
Director Steve E. Krognes acquired 53,528 stock options in Pliant Therapeutics on June 13, 2024, at an exercise price of $13.06.
NASDAQ
PLRX
Pliant Therapeutics, INC
Form 4: Pliant Therapeutics CFO Exercises Stock Options and Acquires Shares
Keith Lamont Cummings, CFO of Pliant Therapeutics, exercised stock options and acquired 21,000 shares of common stock at $2.08 per share on May 2, 2024.